StockData
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc. (UNCY) stock

UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$3.35−0.18 (-5.10%)

Close on Nov 20, 2026Market cap $93.32MP/E –Yield –

Unicycive Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Unicycive Therapeutics's price to sales ratio was 57.7× on Apr 30, 2024.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Apr 30, 202457.7×+13.0
2023Dec 29, 202344.7×–

More Unicycive Therapeutics figures

See a number that looks wrong?